
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVELs research and development has led to innovative treatments for patient populations with a clinical need for systemic photoprotection, DNA repair and acute or life threatening conditions. These patient groups range in size from 5,000 to 45 million worldwide. CLINUVELs lead compound, SCENESSE (afamelanotide 16mg),...
Drug development,drug commercialisation,photomedicine,rare diseases,pharmaceutical,photoprotection,erythropoietic protoporphyria,photocare,and biotechnology
Clinuvel pharmaceuticals ltd operates in the Biotechnology research industry.
Clinuvel pharmaceuticals ltd's revenue is 1b+
Clinuvel pharmaceuticals ltd has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.